Key Points Bitcoin is down 20% in 2026, while Ethereum is down 30%. Despite its recent slide in price, Bitcoin could still hit a price of $1 million by 2030. Ethereum remains a powerhouse in DeFi, giving it plenty of upward price potential. 10 stocks we like better than Bitcoin › Almost without exception, every major cryptocurrency is down at least 20% in 2026. And they are down even bigger from t...
Key Points Bitcoin is down 20% in 2026, while Ethereum is down 30%. Despite its recent slide in price, Bitcoin could still hit a price of $1 million by 2030. Ethereum remains a powerhouse in DeFi, giving it plenty of upward price potential. 10 stocks we like better than Bitcoin › Almost without exception, every major cryptocurrency is down at least 20% in 2026. And they are down even bigger from their all-time highs in 2025, back when crypto euphoria reigned supreme. Of course, you can safely avoid many of these cryptocurrencies for now. They're never coming back. However, there are two cryptocurrencies that you can buy on the (really big) dip. They both have the support of institutional investors, yet both appear to be wildly undervalued. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » 1. Bitcoin The obvious pick is Bitcoin (CRYPTO: BTC). It's down 20% in 2026, and nearly 45% from its all-time high of $126,000 in October. Just six months ago, Bitcoin looked like a no-brainer crypto investment pick. But a lot has changed since then. Most notably, the "digital gold" investment thesis for Bitcoin has fallen apart. Gold and Bitcoin are now headed in very different directions. But there's still reason to be hopeful about Bitcoin. After all, the world's most popular cryptocurrency has a long track record of bouncing back from adversity. Dating all the way back to 2013, it has never posted back-to-back losing years. So, after a down year in 2025, Bitcoin should rebound in 2026. Bitcoin is simply in the "bust" phase of its typical four-year boom-or-bust cycle. Just wait a few months, and see what happens. For good reason, investors are still clinging to the notion that Bitcoin will be a $1 million digital asset by 2030. 2. Ethereum Ethereum (CRYPTO: ETH) is also in the midst of a prolonged dip. It's down...
Smile As the U.S.–Iran conflict enters its 18th day, U.S. markets have seen heightened volatility, with major indices and several sectors posting sharp declines that have pushed many stocks into oversold territory. Oversold conditions generally reflect intense selling pressure, but they can also signal the potential for short-term rebounds, particularly so if the underlying fundamentals remain str...
Smile As the U.S.–Iran conflict enters its 18th day, U.S. markets have seen heightened volatility, with major indices and several sectors posting sharp declines that have pushed many stocks into oversold territory. Oversold conditions generally reflect intense selling pressure, but they can also signal the potential for short-term rebounds, particularly so if the underlying fundamentals remain strong. Here are some of the most oversold mid-cap consumer staple stocks this week, based on the RSI (Relative Strength Indicator) momentum indicator. Traders use RSI to spot trend reversals, entry/exit points, and overextended price moves. RSI above 70 indicates the stock may be overbought, while RSI below 30 indicates that the stock may be oversold. The Campbell's Company ( CPB ), RSI - 21; 15-day: -20.6% Treasury Wine Estates ( TSRYF ) ( TSRYY ), RSI - 22; 15-day: -22.7% Lamb Weston ( LW ), RSI - 24; 15-day: -17.3% Molson Coors Beverage ( TAP ), RSI - 25; 15-day: -14.1% The Marzetti Company ( MZTI ), RSI - 28; 15-day: -10.9% Reynolds Consumer Products ( REYN ), RSI - 26; 15-day: -14% Conagra Brands ( CAG ), RSI - 29; 15-day: -16.7% More on consumer staples Molson Coors Beverage Company (TAP) Presents at UBS Global Consumer and Retail Conference Transcript The Campbell's Company (CPB) Q2 2026 Earnings Call Transcript Wall Street Lunch: U.S. CPI Holds Steady In February As Fed Eyes Oil Shock, Core PCE Top and bottom quant-rated midcap consumer staple stocks after latest quarterly results Wells Fargo turns bearish towards major food producers on profit risks
Victory Capital Holdings ( VCTR ) has submitted a revised proposal to acquire Janus Henderson ( JHG ) for a total consideration of $56.84 per share. JHG stockholders will get $40.00 per share in cash and a fixed exchange ratio of 0.250 shares of Victory Capital common stock for each share they own. JHG investors are expected to own ~ 31% in the combined asset manager. The total consideration is ba...
Victory Capital Holdings ( VCTR ) has submitted a revised proposal to acquire Janus Henderson ( JHG ) for a total consideration of $56.84 per share. JHG stockholders will get $40.00 per share in cash and a fixed exchange ratio of 0.250 shares of Victory Capital common stock for each share they own. JHG investors are expected to own ~ 31% in the combined asset manager. The total consideration is based on Victory Capital's closing share price at March 16. JHG shares were 2.64% higher to $51.79 during Tuesday pre-market trading. VCTR shares were +0.83% to $67.92. In late February , Victory ( VCTR ) proposed to acquire Janus Henderson for what was then valued at $57.04 per share—$30 in cash and 0.350 shares of VCTR. VCTR's value has fallen ~8% since then. On March 11, Janus Henderson said that its board has determined that Victory Capital's proposal is not in the best interest of its shareholders. JHG reaffirmed its recommendation of the transaction it already agreed to with Trian Capital Management and General Catalyst. The company's agreement to be taken private by Nelson Peltz's Trian Fund Management and General Catalyst provides a $49.00 cash payout per share. "In contrast to the Victory Proposal, Janus Henderson’s binding merger agreement to be acquired by Trian and General Catalyst is an actionable transaction that offers certain value to shareholders with significantly less closing and execution risk than the Victory Proposal and is on track to be completed on its planned timeline in mid-2026," JHG's board had then concluded. The new amount by VCTR represents a $3.26 additional per share consideration to the prior proposal and reflects a 37% premium to Janus Henderson's unaffected share price as of October 24, 2025. Based on Victory Capital's unaffected share price immediately prior to submitting its initial proposal, Janus Henderson shareholders will receive a total consideration of $59.32 per share, representing a 42% premium to Janus Henderson's unaffected sha...
STORY: From Nvidia's eye-watering outlook to military-ready humanoid robots... This is Tech Weekly. :: Tech Weekly Nvidia raised its outlook for AI chip sales, saying the revenue opportunity could hit at least $1 trillion through 2027. That's a big jump from the $500 billion it foresaw earlier for its Blackwell and Rubin chips this year. "I want to thank Samsung, who manufactures the Groq LP-30 ch...
STORY: From Nvidia's eye-watering outlook to military-ready humanoid robots... This is Tech Weekly. :: Tech Weekly Nvidia raised its outlook for AI chip sales, saying the revenue opportunity could hit at least $1 trillion through 2027. That's a big jump from the $500 billion it foresaw earlier for its Blackwell and Rubin chips this year. "I want to thank Samsung, who manufactures the Groq LP-30 chip for us" At the GTC developer conference in California, CEO Jensen Huang unveiled a new CPU and an AI system built on Groq. Speaking to a huge crowd, Huang said AI was entering a new phase. "Finally, AI is able to do productive work, and therefore, the inflection point of inference has arrived. AI now has to think. In order to think, it has to inference. AI now has to do. In order to do, it has to inference." Staying with Nvidia, Huang also lauded the viral OpenClaw AI agent in sweeping terms. He called it "the most popular open source project in the history of humanity" Saying its rise in weeks had surpassed what Linux achieved in decades. Nissan, Uber and British startup Wayve are to collaborate on developing robotaxis, aiming to roll out a pilot program in Tokyo later this year. They say Nissan Leaf electric vehicles equipped with Wayve's self-driving technology will be made available to customers via Uber. Meta Platforms shares rose following a Reuters report that the social media giant plans to lay off 20% or more of its workforce... to offset heavy spending on AI and bet on productivity gains from the technology. After falling behind in the AI race, Meta has spent heavily in recent years to catch up by building data centers. "Phantom" is Foundation Future Industry's flagship humanoid robot, a 5-foot-11, 176-pound machine. It's designed to carry loads of up to 88 pounds (40 kg) and move at speeds of up to 6.1 km/h (3.8 mph). The robotics startup is aiming to build robots for defense as well as industrial work. It told Reuters that it wants its machines to handle logi...
Getty Images Thesis This week, we've just seen Structure Therapeutics ( GPCR ) release new topline data from the Phase 2 ACCESS II trial. The stock closed about 5% higher yesterday. The initial look is very positive, and it puts the bull case for the stock centring on aleniglipron’s potential to become a best-in-class oral GLP-1 therapy. As for the results, we almost have injectable-level efficacy...
Getty Images Thesis This week, we've just seen Structure Therapeutics ( GPCR ) release new topline data from the Phase 2 ACCESS II trial. The stock closed about 5% higher yesterday. The initial look is very positive, and it puts the bull case for the stock centring on aleniglipron’s potential to become a best-in-class oral GLP-1 therapy. As for the results, we almost have injectable-level efficacy at about 16% weight loss, but also with the convenience of a once-daily pill. The differentiating aspects of the candidate are what make the drug so appealing to investors. So there are also strong and consistent results across multiple Phase 2 studies, and importantly, no evidence of a weight-loss plateau yet. I think this should significantly de-risk its progression into Phase 3. As of now, the company is in a decent place to capture a meaningful share of that rapidly expanding multi-billion-dollar obesity market. However, some investors, because of the scarcity of differentiated oral GLP-1 assets, are starting to view Structure as an attractive acquisition target. So the potential upside here could come from Phase 3 success and commercialisation, but also from strategic interest by a larger pharma player. Aleniglipron As you know, Structure has just announced some very positive top-line data from their Phase 2 trial on aleniglipron. Just briefly, aleniglipron is an investigational oral small-molecule agonist of the GLP-1 receptor, with that receptor now being a pretty well-validated target in obesity and type 2 diabetes, with all the success from big pharma like Eli Lilly ( LLY ) and Novo Nordisk ( NVO ) in recent times. So, mechanistically, it is quite similar in that GLP-1 receptor activation enhances glucose-dependent insulin secretion. This then suppresses glucagon and slows gastric emptying in our bodies. This is particularly important for obesity, since it reduces appetite via central nervous system pathways. But what really differentiates aleniglipron from existi...
Julian Emanuel, chief equity and quantitative strategist at Evercore ISI, says that the reaction of equity markets to the Iran war, coupled with double-digital earnings expectations, “speaks to the resilience of the market, it speaks to the resilience of the economy,” and “speaks to the fact that markets can move higher.” (Source: Bloomberg)
Julian Emanuel, chief equity and quantitative strategist at Evercore ISI, says that the reaction of equity markets to the Iran war, coupled with double-digital earnings expectations, “speaks to the resilience of the market, it speaks to the resilience of the economy,” and “speaks to the fact that markets can move higher.” (Source: Bloomberg)
Colin Anderson Productions pty ltd/DigitalVision via Getty Images Investment Overview Data indicates that less than 14% of actively managed U.S. large-cap funds have beaten the S&P 500 index in the last 10 years. Further, data also indicates that in the last ten years, 40 stocks have consistently outperformed the S&P 500 index. Both these statistics point to one fact; it’s a challenge to beat inde...
Colin Anderson Productions pty ltd/DigitalVision via Getty Images Investment Overview Data indicates that less than 14% of actively managed U.S. large-cap funds have beaten the S&P 500 index in the last 10 years. Further, data also indicates that in the last ten years, 40 stocks have consistently outperformed the S&P 500 index. Both these statistics point to one fact; it’s a challenge to beat index returns on a sustained basis. When I wrote about AerCap Holdings ( AER ) in 2015, I had a strong conviction that the business is attractive and will create value. However, AerCap has surprised by delivering total returns of 252% since coverage as compared to S&P 500 returns of 260%. This data is enough to show that AER stock has been a steady value creator. However, past performance is not a guarantee of similar returns in the future. As I re-initiate coverage on AerCap Holdings with a “ Buy ” rating, my focus is on factors that are likely to ensure that AER stock remains in a long-term uptrend. As a quick overview, AerCap is among the leading players in the global aviation leasing industry. As of December 2025, the company had an owned portfolio of 1,413 passenger aircraft, 88 freighter aircraft, 470 engines, and 323 helicopters. Strong Credit Profile Supports Growth Plans The aircraft leasing industry is capital intensive and it’s therefore important to talk about the fundamentals with a focus on the company’s credit health. The following factors related to AerCap underscore the point that the company has sound fundamentals and there is no credit stress. First : As of December 2025 , AerCap reported a cash buffer of $1.4 billion. Further, considering the undrawn credit lines coupled with the term loan facilities, the total liquidity buffer is $12.4 billion. This implies ample flexibility to meet capital requirements. Second : As of FY24, AerCap had reported an adjusted-debt-to-equity ratio of 2.35. However, as of FY24, the company’s adjusted-debt-to-equity ratio decline...
The post Best Personal Loans in California by Sarah Haggart appeared first on Benzinga . Visit Benzinga to get more great content like this. Need to take out a personal loan in California? Lenders in the Golden State can offer you loans to invest in big purchases or facilitate credit card debt consolidation. Check out Benzinga’s guide to the best personal loans in California to find the right loan...
The post Best Personal Loans in California by Sarah Haggart appeared first on Benzinga . Visit Benzinga to get more great content like this. Need to take out a personal loan in California? Lenders in the Golden State can offer you loans to invest in big purchases or facilitate credit card debt consolidation. Check out Benzinga’s guide to the best personal loans in California to find the right loan and lender for you. Table of contents [ Show ] The Best Personal Loans in California Best for Comparing Lenders: Credible Best for No Origination Fees: SoFi Best for Excellent Credit Score: Marcus Best for Credit Card Consolidation: Payoff by Happy Money Best for Joint Loans: Prosper Personal Loan Considerations Personal Loans vs. Credit Cards Find a Personal Loan Option in California Frequently Asked Questions The Best Personal Loans in California Best for Comparing Lenders: Credible Best for No Origination Fees: SoFi Best for Excellent Credit Score: Marcus Best for Credit Card Consolidation: Payoff by Happy Money Best for Joint Loans: Prosper California’s best personal loans can connect you with the ready cash that you need, and you can use any of these platforms to take back control of your finances. Best for Comparing Lenders: Credible Best For Comparing lenders Overall Rating Read Review get started Disclosure: See Terms* NMLS# DISCLOSURE Credible Operations, Inc. NMLS# 1681276 Credible. Not available in all states. www.nmlsconsumeraccess.org. 110 Corcoran Street, 5th Floor, Suite 151 Durham, NC 27701 Credible Operations, Inc. NMLS# 1681276, “Credible.” Not available in all states. All bonus payments are by gift card. See terms: https://www.credible.com/legal-pages/bonusrewards Prequalified rates are based on the information you provide and a soft credit inquiry. Receiving prequalified rates does not guarantee that the Lender will extend you an offer of credit. You are not yet approved for a loan or a specific rate. All credit decisions, including loan approval, if an...
Nvidia (NVDA +1.63%) gets the lion's share of AI headlines, but I'm investing in AMD (AMD +1.63%) instead in my own stock portfolio. Here's a rundown of why I'm a fan of AMD right now, and why I think it could outperform its larger counterpart for years to come. *Stock prices used were the morning prices of March 11, 2026. The video was published on March 17, 2026.
Nvidia (NVDA +1.63%) gets the lion's share of AI headlines, but I'm investing in AMD (AMD +1.63%) instead in my own stock portfolio. Here's a rundown of why I'm a fan of AMD right now, and why I think it could outperform its larger counterpart for years to come. *Stock prices used were the morning prices of March 11, 2026. The video was published on March 17, 2026.
National Bank of Canada FI lifted its holdings in shares of Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM - Free Report) by 86.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 786,416 shares of the semiconductor company's stock after buying an additional 363,894 shares during the quarter. ...
National Bank of Canada FI lifted its holdings in shares of Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM - Free Report) by 86.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 786,416 shares of the semiconductor company's stock after buying an additional 363,894 shares during the quarter. National Bank of Canada FI's holdings in Taiwan Semiconductor Manufacturing were worth $219,628,000 at the end of the most recent quarter. Several other institutional investors and hedge funds also recently bought and sold shares of the business. Brighton Jones LLC boosted its holdings in shares of Taiwan Semiconductor Manufacturing by 20.9% in the fourth quarter. Brighton Jones LLC now owns 10,930 shares of the semiconductor company's stock worth $2,159,000 after acquiring an additional 1,892 shares during the period. Geode Capital Management LLC raised its stake in shares of Taiwan Semiconductor Manufacturing by 6.8% during the 2nd quarter. Geode Capital Management LLC now owns 676,178 shares of the semiconductor company's stock valued at $153,148,000 after purchasing an additional 43,139 shares during the period. PAX Financial Group LLC bought a new stake in shares of Taiwan Semiconductor Manufacturing during the 2nd quarter valued at $260,000. Thames Capital Management LLC lifted its holdings in Taiwan Semiconductor Manufacturing by 376.9% during the 2nd quarter. Thames Capital Management LLC now owns 65,127 shares of the semiconductor company's stock worth $14,751,000 after purchasing an additional 51,471 shares in the last quarter. Finally, Sierra Capital LLC boosted its stake in Taiwan Semiconductor Manufacturing by 3.2% in the 2nd quarter. Sierra Capital LLC now owns 4,589 shares of the semiconductor company's stock worth $1,039,000 after purchasing an additional 142 shares during the period. 16.51% of the stock is owned by institutional investors. Get TSM alerts: S...
↗️ Uber Technology (UBER): The ride-hailing company’s stock jumped nearly 4% ahead of the opening bell after Uber and Nvidia said Monday they were expanding their self-driving-vehicle partnership. ↗️ Hyundai Motor (KR:005380), Kia (KR:000270), Nissan Motor (JP:7201), Isuzu Motors (JP: 7202), Geely Automotive (HK:175): Shares of the Asian auto makers all moved higher after Nvidia announced Monday i...
↗️ Uber Technology (UBER): The ride-hailing company’s stock jumped nearly 4% ahead of the opening bell after Uber and Nvidia said Monday they were expanding their self-driving-vehicle partnership. ↗️ Hyundai Motor (KR:005380), Kia (KR:000270), Nissan Motor (JP:7201), Isuzu Motors (JP: 7202), Geely Automotive (HK:175): Shares of the Asian auto makers all moved higher after Nvidia announced Monday it was expanding its autonomous-driving partnership with them.
Andrzej Rostek/iStock via Getty Images At the end of October 2025, I published my last article about Coloplast A/S ( CLPBF ), and in the article I argued that Coloplast is already undervalued and might finally be worth buying now. In the conclusion of my last article, I wrote: Coloplast is certainly not a screaming bargain at this point. It might be a little bit undervalued at this point, but we m...
Andrzej Rostek/iStock via Getty Images At the end of October 2025, I published my last article about Coloplast A/S ( CLPBF ), and in the article I argued that Coloplast is already undervalued and might finally be worth buying now. In the conclusion of my last article, I wrote: Coloplast is certainly not a screaming bargain at this point. It might be a little bit undervalued at this point, but we might find several other stocks that are trading much more below a calculated intrinsic value. Nevertheless, I would see Coloplast as a good investment at this point and will finally rate it as a “Buy” because I think it is a safe bet over the long run. Maybe we will achieve only an annual return of 10% with an investment, but due to the recession-resilient nature, the wide economic moat, and very stable numbers it is reporting, the risk of Coloplast underperforming is limited. Despite rating the stock as a “Buy,” I, personally, did not buy the stock yet. And in the meantime, the stock declined another 24% since my last article was published and is now trading almost 60% below its previous all-time high. In the following article, I will argue that Coloplast is a clear “Buy” at this point and in my opinion a great long-term investment right now. In the following article, I will show why Coloplast is not only undervalued right now, but why we can expect the business to continue to grow with a solid pace and probably in the mid-to-high single digits over the long run. Quarterly Results We start by looking at the last quarterly results and see the business actually struggling a little bit. In the first quarter, revenue increased slightly from DKK 7,026 million in Q1-24/25 to DKK 7,043 million in Q1-25/26 – resulting in only 0.2% year-over-year growth. However, organic growth was 6% in the fourth quarter and especially currency effects had a negative impact (4% decline) and divestitures also led to a decline of 1% for the top line. Operating income declined from DKK 1,912 million...
Nvidia (NASDAQ: NVDA) gets the lion's share of AI headlines, but I'm investing in AMD (NASDAQ: AMD) instead in my own stock portfolio. Here's a rundown of why I'm a fan of AMD right now, and why I think it could outperform its larger counterpart for years to come. *Stock prices used were the morning prices of March 11, 2026. The video was published on March 17, 2026. Continue reading
Nvidia (NASDAQ: NVDA) gets the lion's share of AI headlines, but I'm investing in AMD (NASDAQ: AMD) instead in my own stock portfolio. Here's a rundown of why I'm a fan of AMD right now, and why I think it could outperform its larger counterpart for years to come. *Stock prices used were the morning prices of March 11, 2026. The video was published on March 17, 2026. Continue reading